ID   SSL3_STAA8              Reviewed;         356 AA.
AC   Q2G0X7;
DT   03-JUL-2019, integrated into UniProtKB/Swiss-Prot.
DT   21-MAR-2006, sequence version 1.
DT   25-MAY-2022, entry version 87.
DE   RecName: Full=Staphylococcal superantigen-like 3 {ECO:0000303|PubMed:22665377};
DE   Flags: Precursor;
GN   Name=ssl3 {ECO:0000303|PubMed:22665377};
GN   OrderedLocusNames=SAOUHSC_00386;
OS   Staphylococcus aureus (strain NCTC 8325 / PS 47).
OC   Bacteria; Firmicutes; Bacilli; Bacillales; Staphylococcaceae;
OC   Staphylococcus.
OX   NCBI_TaxID=93061;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RC   STRAIN=NCTC 8325 / PS 47;
RA   Gillaspy A.F., Worrell V., Orvis J., Roe B.A., Dyer D.W., Iandolo J.J.;
RT   "The Staphylococcus aureus NCTC 8325 genome.";
RL   (In) Fischetti V., Novick R., Ferretti J., Portnoy D., Rood J. (eds.);
RL   Gram positive pathogens, 2nd edition, pp.381-412, ASM Press, Washington
RL   D.C. (2006).
RN   [2]
RP   FUNCTION, AND INTERACTION WITH HOST TLR2.
RX   PubMed=22665377; DOI=10.1128/iai.00399-12;
RA   Yokoyama R., Itoh S., Kamoshida G., Takii T., Fujii S., Tsuji T.,
RA   Onozaki K.;
RT   "Staphylococcal superantigen-like protein 3 binds to the Toll-like receptor
RT   2 extracellular domain and inhibits cytokine production induced by
RT   Staphylococcus aureus, cell wall component, or lipopeptides in murine
RT   macrophages.";
RL   Infect. Immun. 80:2816-2825(2012).
RN   [3]
RP   FUNCTION, INTERACTION WITH HOST TLR2, AND MUTAGENESIS OF ARG-338.
RC   STRAIN=NCTC 8325 / PS 47;
RX   PubMed=22714643; DOI=10.1007/s00109-012-0926-8;
RA   Bardoel B.W., Vos R., Bouman T., Aerts P.C., Bestebroer J., Huizinga E.G.,
RA   Brondijk T.H., van Strijp J.A., de Haas C.J.;
RT   "Evasion of Toll-like receptor 2 activation by staphylococcal superantigen-
RT   like protein 3.";
RL   J. Mol. Med. 90:1109-1120(2012).
RN   [4]
RP   FUNCTION, AND SUBCELLULAR LOCATION.
RC   STRAIN=NCTC 8325 / PS 47;
RX   PubMed=28858870; DOI=10.1159/000479100;
RA   Koymans K.J., Goldmann O., Karlsson C.A.Q., Sital W., Thaenert R.,
RA   Bisschop A., Vrieling M., Malmstroem J., van Kessel K.P.M., de Haas C.J.C.,
RA   van Strijp J.A.G., Medina E.;
RT   "The TLR2 Antagonist Staphylococcal Superantigen-Like Protein 3 Acts as a
RT   Virulence Factor to Promote Bacterial Pathogenicity in vivo.";
RL   J. Innate Immun. 9:561-573(2017).
RN   [5]
RP   X-RAY CRYSTALLOGRAPHY (1.94 ANGSTROMS) OF 164-356, MUTAGENESIS OF PHE-186
RP   AND PHE-188, FUNCTION, INTERACTION WITH HOST TLR2, AND DOMAIN.
RX   PubMed=26283364; DOI=10.1073/pnas.1502026112;
RA   Koymans K.J., Feitsma L.J., Brondijk T.H., Aerts P.C., Lukkien E.,
RA   Loessl P., van Kessel K.P., de Haas C.J., van Strijp J.A., Huizinga E.G.;
RT   "Structural basis for inhibition of TLR2 by staphylococcal superantigen-
RT   like protein 3 (SSL3).";
RL   Proc. Natl. Acad. Sci. U.S.A. 112:11018-11023(2015).
RN   [6]
RP   X-RAY CRYSTALLOGRAPHY (1.75 ANGSTROMS) OF 31-356, AND DOMAIN.
RG   Center for Structural Genomics of Infectious Diseases (CSGID);
RA   Minasov G., Nocadello S., Shuvalova L., Filippova E.V., Halavaty A.,
RA   Dubrovska I., Bagnoli F., Falugi F., Bottomley M., Grandi G.,
RA   Anderson W.F.;
RT   "1.75 Angstrom Crystal Structure of Superantigen-like Protein, Exotoxin
RT   from Staphylococcus aureus, in Complex with Sialyl-LewisX.";
RL   Submitted (FEB-2016) to the PDB data bank.
CC   -!- FUNCTION: Secreted protein that plays an essential role in immune
CC       innate response inhibition by interacting with and inhibiting host
CC       TLR2. In turn, bacteria recognition by immune cells is impaired and
CC       cytokine production is inhibited (PubMed:22665377, PubMed:22714643).
CC       Mechanistically, by interacting with TLR2, blocks ligand binding and
CC       thus inhibits activation (PubMed:26283364). Second, by interacting with
CC       an already formed TLR2-lipopeptide complex, prevents TLR
CC       heterodimerization and downstream signaling. The interaction with host
CC       TLR2 does not involve sialyl Lewis X interactions (PubMed:26283364).
CC       {ECO:0000269|PubMed:22665377, ECO:0000269|PubMed:22714643,
CC       ECO:0000269|PubMed:26283364}.
CC   -!- SUBUNIT: Interacts with host TLR2 (via its extracellular domain).
CC       {ECO:0000269|PubMed:22665377, ECO:0000269|PubMed:22714643,
CC       ECO:0000269|PubMed:26283364}.
CC   -!- SUBCELLULAR LOCATION: Secreted {ECO:0000269|PubMed:28858870}.
CC   -!- DOMAIN: The C-terminal domain contains a V-shape binding site for
CC       sialyl Lewis X. {ECO:0000269|PubMed:26283364}.
CC   -!- SIMILARITY: Belongs to the staphylococcal/streptococcal toxin family.
CC       {ECO:0000305}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; CP000253; ABD29550.1; -; Genomic_DNA.
DR   RefSeq; WP_000784023.1; NZ_LS483365.1.
DR   RefSeq; YP_498973.1; NC_007795.1.
DR   PDB; 5D3D; X-ray; 1.94 A; A/B=164-356.
DR   PDB; 5D3I; X-ray; 3.20 A; B=164-356.
DR   PDB; 5I4D; X-ray; 1.75 A; A/B=31-356.
DR   PDBsum; 5D3D; -.
DR   PDBsum; 5D3I; -.
DR   PDBsum; 5I4D; -.
DR   AlphaFoldDB; Q2G0X7; -.
DR   SMR; Q2G0X7; -.
DR   STRING; 1280.SAXN108_0478; -.
DR   UniLectin; Q2G0X7; -.
DR   EnsemblBacteria; ABD29550; ABD29550; SAOUHSC_00386.
DR   GeneID; 3919122; -.
DR   KEGG; sao:SAOUHSC_00386; -.
DR   PATRIC; fig|93061.5.peg.355; -.
DR   HOGENOM; CLU_054950_1_0_9; -.
DR   OMA; FMNVIPD; -.
DR   Proteomes; UP000008816; Chromosome.
DR   GO; GO:0005576; C:extracellular region; IEA:UniProtKB-SubCell.
DR   InterPro; IPR008992; Enterotoxin.
DR   InterPro; IPR015282; SSL_OB.
DR   InterPro; IPR006126; Staph/Strept_toxin_CS.
DR   InterPro; IPR008375; Staph_exotoxin.
DR   InterPro; IPR016091; SuperAg_toxin_C.
DR   InterPro; IPR013307; Superantigen_bac.
DR   Pfam; PF09199; SSL_OB; 1.
DR   PRINTS; PR01898; SAGSUPRFAMLY.
DR   PRINTS; PR01800; STAPHEXOTOXN.
DR   SUPFAM; SSF50203; SSF50203; 1.
DR   SUPFAM; SSF54334; SSF54334; 1.
DR   PROSITE; PS00278; STAPH_STREP_TOXIN_2; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Reference proteome; Secreted; Signal; Virulence.
FT   SIGNAL          1..30
FT                   /evidence="ECO:0000255"
FT   CHAIN           31..356
FT                   /note="Staphylococcal superantigen-like 3"
FT                   /evidence="ECO:0000255"
FT                   /id="PRO_0000447509"
FT   REGION          61..165
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          228..326
FT                   /note="Sialyl Lewis X-binding"
FT                   /evidence="ECO:0000269|PubMed:26283364"
FT   COMPBIAS        71..100
FT                   /note="Basic and acidic residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        101..163
FT                   /note="Polar residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   MUTAGEN         186
FT                   /note="F->A: About 100-fold reduction in cytokine
FT                   production, when associated with A-188."
FT                   /evidence="ECO:0000269|PubMed:26283364"
FT   MUTAGEN         188
FT                   /note="F->A: About 100-fold reduction in cytokine
FT                   production, when associated with A-188."
FT                   /evidence="ECO:0000269|PubMed:26283364"
FT   MUTAGEN         338
FT                   /note="R->A: About 75% loss of human TLR2 binding."
FT                   /evidence="ECO:0000269|PubMed:22714643"
FT   HELIX           169..174
FT                   /evidence="ECO:0007829|PDB:5I4D"
FT   STRAND          180..189
FT                   /evidence="ECO:0007829|PDB:5I4D"
FT   STRAND          193..196
FT                   /evidence="ECO:0007829|PDB:5I4D"
FT   STRAND          198..201
FT                   /evidence="ECO:0007829|PDB:5I4D"
FT   STRAND          203..206
FT                   /evidence="ECO:0007829|PDB:5I4D"
FT   STRAND          208..211
FT                   /evidence="ECO:0007829|PDB:5I4D"
FT   HELIX           216..219
FT                   /evidence="ECO:0007829|PDB:5I4D"
FT   STRAND          225..232
FT                   /evidence="ECO:0007829|PDB:5I4D"
FT   STRAND          242..247
FT                   /evidence="ECO:0007829|PDB:5I4D"
FT   STRAND          249..251
FT                   /evidence="ECO:0007829|PDB:5I4D"
FT   STRAND          259..268
FT                   /evidence="ECO:0007829|PDB:5I4D"
FT   STRAND          274..283
FT                   /evidence="ECO:0007829|PDB:5I4D"
FT   STRAND          286..289
FT                   /evidence="ECO:0007829|PDB:5I4D"
FT   HELIX           290..305
FT                   /evidence="ECO:0007829|PDB:5I4D"
FT   TURN            307..309
FT                   /evidence="ECO:0007829|PDB:5I4D"
FT   STRAND          314..320
FT                   /evidence="ECO:0007829|PDB:5I4D"
FT   STRAND          325..329
FT                   /evidence="ECO:0007829|PDB:5I4D"
FT   HELIX           336..340
FT                   /evidence="ECO:0007829|PDB:5I4D"
FT   STRAND          342..344
FT                   /evidence="ECO:0007829|PDB:5I4D"
FT   HELIX           345..347
FT                   /evidence="ECO:0007829|PDB:5I4D"
FT   STRAND          348..355
FT                   /evidence="ECO:0007829|PDB:5I4D"
SQ   SEQUENCE   356 AA;  40181 MW;  32C655251E8E87A5 CRC64;
     MKMRTIAKTS LALGLLTTGA ITVTTQSVKA EKIQSTKVDK VPTLKAERLA MINITAGANS
     ATTQAANTRQ ERTPKLEKAP NTNEEKTSAS KIEKISQPKQ EEQKTLNISA TPAPKQEQSQ
     TTTESTTPKT KVTTPPSTNT PQPMQSTKSD TPQSPTIKQA QTDMTPKYED LRAYYTKPSF
     EFEKQFGFML KPWTTVRFMN VIPNRFIYKI ALVGKDEKKY KDGPYDNIDV FIVLEDNKYQ
     LKKYSVGGIT KTNSKKVNHK VELSITKKDN QGMISRDVSE YMITKEEISL KELDFKLRKQ
     LIEKHNLYGN MGSGTIVIKM KNGGKYTFEL HKKLQEHRMA DVIDGTNIDN IEVNIK
//
